Catherine M Burzik - Net Worth and Insider Trading

Catherine M Burzik Net Worth

The estimated net worth of Catherine M Burzik is at least $3 Million dollars as of 2024-05-02. Catherine M Burzik is the Director of Becton Dickinson & Co and owns about 10,007 shares of Becton Dickinson & Co (BDX) stock worth over $2 Million. Catherine M Burzik is the Senior Vice President of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA and owns about 23,416 shares of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) stock worth over $538,100. Catherine M Burzik is also the Director of Orthofix Medical Inc and owns about 7,947 shares of Orthofix Medical Inc (OFIX) stock worth over $105,218. Details can be seen in Catherine M Burzik's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Catherine M Burzik has not made any transactions after 2021-11-19 and currently still holds the listed stock(s).

Transaction Summary of Catherine M Burzik

To

Catherine M Burzik Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Catherine M Burzik owns 4 companies in total, including Haemonetics Corp (HAE) , Becton Dickinson & Co (BDX) , and Veradigm Inc (MDRX) among others .

Click here to see the complete history of Catherine M Burzik’s form 4 insider trades.

Insider Ownership Summary of Catherine M Burzik

Ticker Comapny Transaction Date Type of Owner
HAE Haemonetics Corp 2016-10-25 director
BDX Becton Dickinson & Co 2022-01-25 director
MDRX Veradigm Inc 2011-10-25 director
2021-11-19 director

Catherine M Burzik Latest Holdings Summary

Catherine M Burzik currently owns a total of 3 stocks. Among these stocks, Catherine M Burzik owns 10,007 shares of Becton Dickinson & Co (BDX) as of April 17, 2019, with a value of $2 Million and a weighting of 78.9%. Catherine M Burzik owns 23,416 shares of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) as of August 2, 2006, with a value of $538,100 and a weighting of 17.65%. Catherine M Burzik also owns 7,947 shares of Orthofix Medical Inc (OFIX) as of November 19, 2021, with a value of $105,218 and a weighting of 3.45%.

Latest Holdings of Catherine M Burzik

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BDX Becton Dickinson & Co 2019-04-17 10,007 240.35 2,405,182
ABI Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA 2006-08-02 23,416 22.98 538,100
OFIX Orthofix Medical Inc 2021-11-19 7,947 13.24 105,218

Holding Weightings of Catherine M Burzik


Catherine M Burzik Form 4 Trading Tracker

According to the SEC Form 4 filings, Catherine M Burzik has made a total of 0 transactions in Becton Dickinson & Co (BDX) over the past 5 years. The most-recent trade in Becton Dickinson & Co is the sale of 45 shares on April 17, 2019, which brought Catherine M Burzik around $10,037.

According to the SEC Form 4 filings, Catherine M Burzik has made a total of 0 transactions in Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) over the past 5 years. The most-recent trade in Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA is the sale of 668 shares on August 2, 2006, which brought Catherine M Burzik around $21,590.

According to the SEC Form 4 filings, Catherine M Burzik has made a total of 1 transactions in Orthofix Medical Inc (OFIX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Orthofix Medical Inc is the acquisition of 1,660 shares on November 19, 2021, which cost Catherine M Burzik around $50,248.

Insider Trading History of Catherine M Burzik

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Catherine M Burzik Trading Performance

GuruFocus tracks the stock performance after each of Catherine M Burzik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catherine M Burzik is 2.95%. GuruFocus also compares Catherine M Burzik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catherine M Burzik within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Catherine M Burzik's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Catherine M Burzik

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.61
Relative Return to S&P 500(%) -3.26

Catherine M Burzik Ownership Network

Ownership Network List of Catherine M Burzik

No Data

Ownership Network Relation of Catherine M Burzik


Catherine M Burzik Owned Company Details

What does Haemonetics Corp do?

Who are the key executives at Haemonetics Corp?

Catherine M Burzik is the director of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP & Chief Technology Officer Anila Lingamneni , and EVP & Global Manufacturing Josep Llorens .

Haemonetics Corp (HAE) Insider Trades Summary

Over the past 18 months, Catherine M Burzik made no insider transaction in Haemonetics Corp (HAE). Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 7,319 shares made by Josep Llorens , a net sale of 4,609 shares made by Anila Lingamneni , and a net sale of 2,766 shares made by Stewart W Strong .

In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,909 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,909 shares.

Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Haemonetics Corp Insider Transactions

No Available Data

Catherine M Burzik Mailing Address

Above is the net worth, insider trading, and ownership report for Catherine M Burzik. Currently GuruFocus does not have mailing address information for Catherine M Burzik.

Discussions on Catherine M Burzik

No discussions yet.